Does arachidonic acid release lead to prostaglandin and leukotriene-driven inflammation?

The biochemical pathway through which arachidonic acid (AA) transitions from a membrane structural component to a potent inflammatory signal is a cornerstone of human immunology and pharmacology. This process involves precise enzymatic release and metabolic conversion into bioactive mediators.

Mechanistic pathways of release and conversion

The synthesis of inflammatory mediators begins with the liberation of arachidonic acid from its storage site.

• Membrane release: AA is primarily sequestered in the sn-2 position of cell membrane phospholipids. Upon cellular activation (often by calcium influx or cytokine signaling), the enzyme cytosolic phospholipase A2 (cPLA2) hydrolyzes the phospholipid bond, releasing free AA into the cytoplasm.
• The COX pathway: Free AA is metabolized by cyclooxygenase enzymes (COX-1 and COX-2) into prostaglandin H2 (PGH2). This precursor is then converted by specific synthases into various prostaglandins, such as PGE2 and PGD2, which mediate pain, fever, and vasodilation.
• The LOX pathway: Alternatively, AA is processed by lipoxygenase enzymes, primarily 5-LOX, to produce 5-HPETE. This is subsequently converted into leukotrienes (e.g., LTA4, LTB4, LTC4), which are critical for leukocyte recruitment and bronchial constriction.

Amplification of inflammatory signaling

Prostaglandins and leukotrienes do not merely signal; they actively amplify the immune response through several feed-forward mechanisms.

• Receptor activation: These mediators bind to specific G-protein-coupled receptors (GPCRs). For example, PGE2 binding to EP receptors triggers intracellular cascades that increase the production of pro-inflammatory cytokines like IL-6 and TNF-α.
• NF-κB signaling loops: Eicosanoid signaling activates the NF-κB transcription factor, which upregulates the expression of COX-2 and other inflammatory genes. This creates a self-sustaining loop where the presence of prostaglandins leads to the production of more enzymes to synthesize even more prostaglandins.
• Eicosanoid storms: In severe inflammatory states, this amplification can escalate into an "eicosanoid storm," driving excessive vascular permeability and leukocyte infiltration, often preceding or accompanying cytokine storms.

Bottom line

The claim is fully supported by established science. Arachidonic acid is released from cell membranes by PLA2 and converted into prostaglandins and leukotrienes via the COX and LOX pathways, respectively. These mediators then amplify inflammation by activating GPCR-mediated pathways and inducing feed-forward loops that increase cytokine production and enzyme expression.